Last reviewed · How we verify
NCT03836534
the Observance of Emergency Exit Treatments During the Stay of Care at the Exit of Reims Emergencies
trial testing adherence to treatment of patients coming out of emergencies in Patient Coming to the Emergency Department for Any Reason in 274 participants. Completed in 31 March 2019.
18 March 2019
Quick facts
| Lead sponsor | CHU de Reims |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 274 |
| Start date | 11 March 2019 |
| Primary completion | 18 March 2019 |
| Estimated completion | 31 March 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- adherence to treatment of patients coming out of emergencies
Conditions studied
- Patient Coming to the Emergency Department for Any Reason — all drugs for Patient Coming to the Emergency Department for Any Reason →
Sponsor
CHU de Reims — full company profile →
Who can join
18 and older, any sex, with Patient Coming to the Emergency Department for Any Reason. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators would like to include patients consulting in a Accident and Emergency Department (AED) during the permanence of care the week of March 11 to 17, 2018. The data collection would concern socio-demographic data, their consultation to the AED, the follow-up given to the consultation and would take place by telephone contact of patients within 48 hours of the consultation. why patients come to the emergency room, what are they waiting for? what are their main motivations? what do they do in emergencies, do they follow the treatments and recommendations?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03836534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other CHU de Reims trials
Trials by the same sponsor.
- NCT06955767 — Measurement of MMP-14 Protein, a Potential New Marker for Colorectal Cancer Detection, in Plasma Vesicles Named Exosomes · NA · recruiting
- NCT07163338 — Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS) · NA · recruiting
- NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
- NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
- NCT07016035 — Translation and Validation of the French mPCOSQ (mPCOSQ-F). · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03836534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CHU de Reims
- Last refreshed: 2 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03836534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing